Skip to main content
. 2023 Feb 23;18:39. doi: 10.1186/s13023-023-02629-1

Table 3.

Details of reviewed studies about neurofibromatosis type 1, according to location, sample, method design and significant outcomes

Setting Method Results Study quality
Ref. Location N Design (strength) Tools Comparator(s) IV(s) DV(s) Significant outcomes
Foji et al. [121] Iran 24 Exploratory -qualitative (low) Interview w/ evolving structure (GTM) N/A N/A N/A

NF1 patients’ life & their response to failure & falling behind in life ‘an unsuccessful struggle to escape’

Environmental conditions: unpleasant appearance due to spots & tumors; inability to have kids; learning disabilities; limitations daily life activities; social rejection and isolation; facing aggression form others; perception of no social support; incurability of NF1

Indivuals’ responses/coping: hiding disease from others; seeking isolation; complaining to God; refusing to receive care; hopelessness; In extreme cases: suicidal ideation, unsuccessful suicide attempts

High
Fjermestad et al. [123] Norway 142 Cross-sectional—quantitative (low) Questionnaires (HUNT3; OGs) 46,393 non-affected subjects (extracted from a cohort study) Biomedical datas; Mental functioning; Health related QoL Life satisfaction

HrQoL problems↑ in following domains: life satisfaction, mental health, sleep, pain, gastrointestnal problems, oral health, memory problems, social support (especially women)

MLR model → life satisfaction: mental health, sleep, pain, memory problems, social support***

Only mental health was a unique significant predictor***

Moderate
Jensen et al. [115] USA 16 Exploratory -qualitative (low) Semi-structured interviews (TCA) N/A N/A N/A Chronic pain & acute episodes of localized pain; social functioning (limited activity participation, role limitation & relationship impact); mobility difficulties; internalized stigma (more external in youth) Moderate
Rosnau et al. [116] USA 49 Cross-sectional—quantitative (low) Questionnaires (RSES; OGs) General population norms (Sinclair et al. 2010) Biomedical datas; NF1 experiences Self-esteem (SE); NF1 knowledge

¾ of the participants had a quite good knowledge about NF1

NF1 SE↓ vs. general pop. norms***

MLR model → SE: learning problems, having friends with NF1, attending a support group & receiving genetic counseling*

High
Bicudo et al. [119] Brazil 13 Cross-sectional mixed—quali-quantitative (moderate) Hetero-assessment scale (Ablon & Riccardi); questionnaires (WHOQOL-100) & Semi-structured interviews (TCA) 39 non-affected subjects NF1 severity & visibility Quality of Life

No significant impact of NF1 on QoL

Difficulties: pain; concern about the future; shame; discomfort; awkwardness; hiding body; concern about genetic counseling; limited job opportunity & professional life; NF1 as a curiosity for strangers; confusion from strangers with contagious diseases; social prejudices; inappropriate healthcare; lack of information

Coping: spirituality/religion/beliefs; relativizing NF1; social support (e.g. family); resection of pNF

Moderate
Crawford et al. [122] Australia 60 Exploratory -qualitative (low) Interview w/ evolving structure (GTM) N/A N/A N/A Cosmetic disfigurement as a burden; social discomfort & awkwardness; difficulty in finding partners; lack of awareness and knowledge of NF1 in society; learning and/or attention difficulties in childhood; affected aspirations & self-esteem; genetic inheritance concerns; unpredictable disease progression; pain High
Barke et al. [117] England 9 Exploratory -qualitative (low) Semi-structured interviews (TCA) N/A N/A N/A NF1 impacts differs a lot (severity & visibility); social discomfort & awkwardness; social support (family, friends, online support group); adolescence as a period of learning & awareness about NF1; NF1 poorly understood (medical community, medias); unpredictable disease progression Moderate
Hummelvoll & Antonsen [120] Norway 15 Exploratory -qualitative (low) Semi-structured interviews (TCA +) N/A N/A N/A Pain (sleep disturbance, fatigue); movement & mobility difficulties; anxio-depressive symptoms; the importance of family background and relations; the role of friendships; low self-confidence; dealing with NF1 visibility; unpredictable disease progression; personal/cognitive aspects mediates the impact of NF1 High
Smith et al. [126] USA 127 ♀ Cross-sectional—quantitative (moderate) Questionnaires (DAS59; RSES; UCLA Loneliness Scale) 48 NF2 ♀ + General population & Breast Cancer Survivors’ (BCS) norms (extracted from other studies) Appearance distress / self-consciousness Self-esteem (SE); Loneliness

NF1 women reported more psychosocial reasons for disliking their feature vs. NF2 women*

NF1 sexual / bodily self-consciousness↑ vs. general pop norms* and BCS***

NF1 social self-consciousness↑ vs. general pop norms and BCS***

NF1 sexual / bodily self-consciousness↑ ↔ SE↓***

NF1 social self-consciousness of appearance↑ ↔ SE↓***; loneliness↑**

High
Granström et al. [127] Germany 228 Cross-sectional—quantitative (low) Hetero-assessment scale (Riccardi); Questionnaires (DLQI; Distress Thermometer; FBeK; OGs) 2047 non-affected subjects + 105 psoriasis subjects (extracted from other studies) Biomedical datas; NF1 severity & visibility; Body Image Depressive statement; Psychological distress; Health-related QoL

NF1 visibility↑ ↔ depressive state↑**, frequency of a lifetime depression diagnosis↑**, psychosocial distress↑***, QoL impairment↑*** and body experience↓***

NF1 patients’ feelings: insecure and uneasy with their own bodies↑***, attractive and self-confident↓*** vs. healthy pop

NF1 visibility effect on depressive state was completely mediated by NF1 patients’ body experience***; partially on psychological distress*** and QoL impairment**

High
Dheensa & Williams [112] England 6 Exploratory -qualitative (low) In-depth semi-structured interviews (IPA) N/A N/A N/A Lack of information about NF1 (no further explanations; loss faith & trust in medical professions); feeling judged (social self-consciousness aroused; isolation/solitude); social comparisons; variety of coping methods; unpredictable disease progression; some positive appraisal Low
Kodra et al. [125] Italia 129 Cross-sectional—quantitative (low) Hetero-assessment scale (Ablon) & Questionnaires (SF-36; Skindex-29) N/A NF1 visibility General & skin-disease-specific QoL

NF1♀ impact on emotions↑** and physical↑*** symptoms vs. for NF1♂

NF1 visibility↑ independently ↔ skin-disease-specific QoL following aspects: emotions↓***, physical symptoms↓* and functioning↓***

Moderate
Page et al. [124] USA 169 Cross-sectional—quantitative (low) Hetero-assessment scale (Ablon & Riccardi); Questionnaires (SF-36; Skindex-29) 154 non-affected U.S. subjects (extracted from another study) NF1 severity & visibility General & skin-disease-specific QoL

NF1 visibility↑ independently → skin-disease-specific QoL following aspects: emotions↓ (♀ especially)**, symptoms↓* & functioning↓***

NF1 severity↑ independently → skin-disease-specific QoL following aspects: symptoms↓*, function↓*

NF1 patients general health QoL↓ vs. normative pop*

NF1 severity↑ independently → general health QoL↓ (physical function, bodily pain, general health perception, vitality, role emotional, mental health, social functioning, role physical, physical symptoms)**

Moderate
Wolkenstein et al. [118] France 128 Cross-sectional—quantitative (low) Hetero-assessment scale (Ablon & Riccardi); Questionnaires (SF-36; Skindex-29) 3656 subjects representative of the French population (extracted from another study) NF1 severity & visibility General & skin-disease-specific QoL

NF1 impact on emotions↑*** & physical symptoms↑** for ♀ vs. ♂

NF1 visibility↑ independently → skin-disease-specific QoL following aspects: emotions↓*, symptoms↓** & functioning↓**

Each aspect of NF1 general health QoL↓ vs. normative pop

NF1 severity independently → 4 aspects of general health QoL: physical function**, bodily pain*, general health perception**, vitality*

NF1 visibility independently → 4 aspects of general health QoL: physical function**, social functioning*, role-emotional*, mental health*

Moderate
Zöller & Rembeck [114] Sweden 70 (1978) → 37 (1990) Longitudinal study—quantitative (12 years follow-up) (moderate) Medical & psychiatric interviews (CPRS); Questionnaires (KSP; SES) 27 non-affected subjects NF1 severity (quantity & location of neurofibromas) Psychiatric characteristics; Personality profile; Self-concept

NF1 patients: mood disorders↑ (depression, dysthymia) vs. non-affected subjects***

NF1 patients: sleep↓*; social phobias↑*; worries about trifles↑** vs. non-affected subjects

NF1 patients w/o psychiatric diagnosis: self-evaluation & socialization↑*; aggressivity↓***; irritability↓** vs. non-affected subjects

No further difference between 1978 & 1990

Moderate
Ablon [113] USA 28 Exploratory -qualitative (low) One question-based interviews N/A Gender Life experiences

♀ ≠ ♂: internalized cosmetic norms & body concerns; parenting prevail over gender; fears of rejection

harder for ♀: genetic inheritance concerns; more binding appearance norms

harder for ♂: compromised manliness; employability & professional life; represses their feelings; tend to withdraw from social life & avoid romantic situations (unlike women)

Low

All study considered socio-demographic aspects (for example: age; gender; education lvl; socio-economic status; profession; etc.)

IV Independent variable; DV Dependent variable; GTM Grounded theory methodology; TCA Thematic content analysis; NF1 Neurofibromatosis type 1; MLR Multiple linear regression; OGs Originals instruments; pop population

A ↔ B: A is associated with B; A → B: A predicts B; A↑: A is higher/more important; A↓: A is lower/less important; with: w/; without: w/o; vs.: compared to…

p < 0.05*; p < 0.01**; p < 0.001***